Lilly Novo Nordisk Battle Intensifies as Obesity Drugs Surge
Eli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Explore well-known S&P 500 index funds for retirement 2024, focusing on performance, costs, and suitability for your plan.
22,695 articlesEli Lilly's Q1 2026 results slam the lid on the GLP-1 duopoly's early calm, with Lilly’s revenue exploding and Novo N...
Two fresh upgrades lifted Intel shares as Jim Cramer proclaimed the company the top name in chips. The stock surged, ...
A Wall Street note imagines a SpaceX IPO delivering about 40% upside, powered by a diversified revenue mix. This repo...
As deal talk returns to tech, we weigh Reddit, Roku, and SoundHound AI for takeover potential. None has a confirmed b...
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...
As AI excitement cools, investors parse the shift from trade short-term bets to a lasting investment decade. BlackRoc...
A new kind of space stock is building recurring AI-powered intelligence from satellites. This article breaks down the...
The House unveiled the Build Housing Affordably Act, a bipartisan bill to suspend specific federal procurement rules ...
Two pharma giants sit at the center of the booming weight-loss drug market. This piece breaks down which could offer ...
Strategy’s flagship STRC yield product slid to yearly lows as Bitcoin volatility intensified, weighing on the company...
Billionaire investor Bill Ackman points to SpaceX's durable cash-flow engines, highlighting a cornerstone of value as...
Claude AI’s world predictions for two World Cup matches produced a mixed bag: a precise call in USA vs Australia and ...